Abstract
Background: In industrialized countries, Staphylococcus aureus (SA) is a leading cause of late-onset neonatal sepsis.
Methods: Culture-proven episodes were identified prospectively from neonatal units participating in the neonatal infection surveillance network. Demographic, risk factor, and outcome data were collected.
Results: Between 2004 and 2009, there were 117 episodes of SA infections (including 8 methicillin-resistant SA) in 116 infants from 13 units. The median gestational age and birth-weight were 27 weeks (90%
Conclusions: SA is the second most common pathogen causing late-onset neonatal infections in this neonatal network. Infants who weigh <1500 g in intensive care settings are the most vulnerable group. Clinical signs are not sufficiently distinctive to allow targeted therapy, suggesting that an antistaphylococcal agent should be part of empiric therapy for late-onset sepsis in premature infants.
Original language | English |
---|---|
Pages (from-to) | 850-854 |
Number of pages | 5 |
Journal | Pediatric Infectious Disease Journal |
Volume | 30 |
Issue number | 10 |
DOIs | |
Publication status | Published - Oct 2011 |
Keywords
- neonatal
- Staphylococcus aureus
- bacteremia
- sepsis
- MRSA
- INTENSIVE-CARE-UNIT
- SCALDED SKIN SYNDROME
- LATE-ONSET SEPSIS
- SURVEILLANCE-SYSTEM
- RESISTANT
- INFECTIONS
- COMMUNITY
- BACTEREMIA
- CHILDREN
- DISEASE